🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/12/2023 | 103,73 | 105,38 | 103,73 | 105,06 | +1,55% | 1,59% | 10.169.900 |
| 01/12/2023 | 102,85 | 103,68 | 102,66 | 103,46 | +0,96% | 0,99% | 6.863.400 |
| 30/11/2023 | 100,84 | 102,69 | 100,28 | 102,48 | +1,33% | 2,39% | 29.299.700 |
| 29/11/2023 | 100,28 | 101,17 | 99,80 | 101,13 | +0,95% | 1,37% | 10.286.800 |
| 28/11/2023 | 101,31 | 101,35 | 100,01 | 100,18 | -1,23% | 1,32% | 8.738.500 |
| 27/11/2023 | 101,91 | 102,15 | 100,70 | 101,43 | -0,43% | 1,42% | 7.356.500 |
| 24/11/2023 | 102,26 | 102,51 | 101,44 | 101,87 | +0,19% | 1,05% | 3.168.000 |
| 22/11/2023 | 102,20 | 102,68 | 101,11 | 101,68 | -0,52% | 1,54% | 5.724.000 |
| 21/11/2023 | 103,00 | 103,63 | 101,85 | 102,21 | -0,46% | 1,73% | 7.403.500 |
| 20/11/2023 | 100,97 | 102,93 | 100,89 | 102,68 | +0,91% | 2,02% | 7.449.900 |
| 17/11/2023 | 102,00 | 102,42 | 100,96 | 101,75 | -0,24% | 1,43% | 6.767.000 |
| 16/11/2023 | 101,83 | 102,06 | 101,03 | 101,99 | +0,63% | 1,01% | 7.889.700 |
| 15/11/2023 | 101,88 | 102,17 | 100,72 | 101,35 | -0,80% | 1,42% | 7.392.600 |
| 14/11/2023 | 102,66 | 103,22 | 101,90 | 102,17 | -0,29% | 1,29% | 6.944.400 |
| 13/11/2023 | 101,09 | 102,55 | 100,58 | 102,47 | +1,07% | 1,95% | 5.878.200 |
| 10/11/2023 | 102,84 | 103,36 | 100,60 | 101,39 | -0,97% | 2,68% | 7.627.100 |
| 09/11/2023 | 104,71 | 104,71 | 102,15 | 102,38 | -1,93% | 2,44% | 7.377.000 |
| 08/11/2023 | 103,98 | 105,17 | 103,84 | 104,40 | +0,38% | 1,28% | 8.152.100 |
| 07/11/2023 | 104,35 | 104,72 | 103,73 | 104,00 | -0,33% | 0,95% | 6.616.400 |
| 06/11/2023 | 104,08 | 104,37 | 103,14 | 104,34 | +0,93% | 1,18% | 5.951.200 |
| 03/11/2023 | 103,37 | 104,25 | 102,78 | 103,38 | +0,52% | 1,42% | 6.005.900 |
| 02/11/2023 | 102,74 | 103,06 | 101,65 | 102,85 | +0,00% | 1,37% | 5.379.100 |
| 01/11/2023 | 103,55 | 104,23 | 102,73 | 102,85 | +0,15% | 1,45% | 5.838.100 |
| 31/10/2023 | 102,77 | 103,55 | 101,40 | 102,70 | +0,02% | 2,09% | 7.522.600 |
| 30/10/2023 | 103,28 | 104,50 | 102,61 | 102,68 | -0,14% | 1,83% | 6.915.500 |
| 27/10/2023 | 105,32 | 105,57 | 102,22 | 102,82 | -2,59% | 3,18% | 8.933.800 |
| 26/10/2023 | 103,10 | 107,23 | 102,99 | 105,55 | +1,85% | 4,11% | 11.335.700 |
| 25/10/2023 | 103,35 | 104,61 | 102,95 | 103,63 | +0,58% | 1,61% | 7.849.200 |
| 24/10/2023 | 103,32 | 104,06 | 102,68 | 103,03 | -0,31% | 1,34% | 6.347.900 |
| 23/10/2023 | 102,83 | 104,15 | 102,67 | 103,35 | +0,66% | 1,44% | 8.493.000 |